Mr Hemant Pachnanda, Director of Strategy and Business Development, Sanofi-Aventis, Singapore will be at Pharma Partnering & Investment World Asia 2012 on the 20th of March, where he will be appearing at a panel with the topic: Comparing business development strategies in Asia. This is part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012.
Firstly, a brief introduction: Mr Pachnanda has more than 10 years of industry experience in areas like such as licensing of products, brands , technologies, acquisitions-technology companies, product companies, strategy planning and portfolio planning. Currently with Sanofi he is the Director for Business Development and Strategy Planning. He is responsible for licensing activites and the evaluation of all diversification projects for Sanofi in the region. He is a post graduate in Biosciences, Pharmaceutical sciences and MBA.
Some issues that Mr Pachnanda will be speaking about include:
1. Understanding the importance of licensing and assessing potential investment opportunities
2. Evaluating common challenges experienced by global pharmas in emerging markets and new strategies that can be implemented
3. Differentiating licensing deal making strategies between emerging and established markets